SOTERA HEALTH CO

NASDAQ: SHC (Sotera Health Company)

Last update: 05 Jun, 9:03PM

12.19

-0.17 (-1.38%)

Previous Close 12.36
Open 12.31
Volume 881,283
Avg. Volume (3M) 1,229,669
Market Cap 3,508,452,608
Price / Earnings (TTM) 135.44
Price / Earnings (Forward) 20.20
Price / Sales 2.93
Price / Book 7.93
52 Weeks Range
9.53 (-21%) — 17.08 (40%)
Earnings Date 4 Aug 2025 - 8 Aug 2025
Profit Margin 4.03%
Operating Margin (TTM) 34.03%
Diluted EPS (TTM) 0.160
Quarterly Revenue Growth (YOY) -6.50%
Quarterly Earnings Growth (YOY) -68.10%
Total Debt/Equity (MRQ) 580.53%
Current Ratio (MRQ) 2.75
Operating Cash Flow (TTM) 224.16 M
Levered Free Cash Flow (TTM) 107.18 M
Return on Assets (TTM) 6.76%
Return on Equity (TTM) 10.46%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bearish Bearish
Diagnostics & Research (Global) Bearish Bearish
Stock Sotera Health Company Bearish Bearish

AIStockmoo Score

0.6
Analyst Consensus -0.5
Insider Activity 3.0
Price Volatility -2.0
Technical Moving Averages 1.0
Technical Oscillators 1.5
Average 0.60

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
SHC 4 B - 135.44 7.93
TWST 2 B - - 4.13
NEOG 1 B - - 0.450
CDNA 834 M - 13.39 2.87
CSTL 619 M - 34.63 1.23
BIAF 12 M - - 5.44

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Core
% Held by Insiders 2.44%
% Held by Institutions 93.96%

Ownership

Name Date Shares Held
Warburg Pincus Llc 31 Mar 2025 73,822,952
Gtcr Llc 31 Mar 2025 49,215,301
Sachem Head Capital Management Lp 31 Mar 2025 7,910,000
52 Weeks Range
9.53 (-21%) — 17.08 (40%)
Price Target Range
12.00 (-1%) — 17.00 (39%)
High 17.00 (Goldman Sachs, 39.46%) Buy
Median 13.00 (6.65%)
Low 12.00 (Barclays, -1.56%) Buy
Average 14.00 (14.85%)
Total 2 Buy, 1 Hold
Avg. Price @ Call 11.46
Firm Date Target Price Call Price @ Call
Goldman Sachs 05 May 2025 17.00 (39.46%) Buy 12.92
Piper Sandler 23 Apr 2025 13.00 (6.64%) Hold 10.87
Barclays 10 Apr 2025 12.00 (-1.56%) Buy 10.60

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria